Literature DB >> 23392275

Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

S P Kar1, M F Seldin, W Chen, E Lu, G M Hirschfield, P Invernizzi, J Heathcote, D Cusi, M E Gershwin, K A Siminovitch, C I Amos.   

Abstract

Genome-wide association studies (GWAS) have successfully identified several loci associated with primary biliary cirrhosis (PBC) risk. Pathway analysis complements conventional GWAS analysis. We applied the recently developed linear combination test for pathways to datasets drawn from independent PBC GWAS in Italian and Canadian subjects. Of the Kyoto Encyclopedia of Genes and Genomes and BioCarta pathways tested, 25 pathways in the Italian dataset (449 cases, 940 controls) and 26 pathways in the Canadian dataset (530 cases, 398 controls) were associated with PBC susceptibility (P<0.05). After correcting for multiple comparisons, only the eight most significant pathways in the Italian dataset had FDR <0.25 with tumor necrosis factor/stress-related signaling emerging as the top pathway (P=7.38 × 10⁻⁴, FDR=0.18). Two pathways, phosphatidylinositol signaling and hedgehog signaling, were replicated in both datasets (P<0.05), and subjected to two additional complementary pathway tests. Both pathway signals remained significant in the Italian dataset on modified gene set enrichment analysis (P<0.05). In both GWAS, variants nominally associated with PBC were significantly overrepresented in the phosphatidylinositol pathway (Fisher exact P<0.05). These results point to established and novel pathway-level associations with inherited predisposition to PBC that, on further independent replication and functional validation, may provide fresh insights into PBC etiology.

Entities:  

Mesh:

Year:  2013        PMID: 23392275      PMCID: PMC3780793          DOI: 10.1038/gene.2013.1

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  46 in total

Review 1.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

Review 2.  Analysing biological pathways in genome-wide association studies.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nat Rev Genet       Date:  2010-12       Impact factor: 53.242

Review 3.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

4.  Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.

Authors:  M Eric Gershwin; Carlo Selmi; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Keith D Lindor; Marshall M Kaplan; John M Vierling
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

5.  Transcription factor Zic2 inhibits Wnt/β-catenin protein signaling.

Authors:  Rasoul Pourebrahim; Rob Houtmeyers; Stephen Ghogomu; Sylvie Janssens; Aurore Thelie; Hong Thi Tran; Tobias Langenberg; Kris Vleminckx; Eric Bellefroid; Jean-Jacques Cassiman; Sabine Tejpar
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

6.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

7.  PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role.

Authors:  Mitsuyoshi Utsugi; Kunio Dobashi; Akihiro Ono; Tamotsu Ishizuka; Shin-ichi Matsuzaki; Takeshi Hisada; Yasuo Shimizu; Tadayoshi Kawata; Haruka Aoki; Yosuke Kamide; Masatomo Mori
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

9.  Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset.

Authors:  Hongsheng Gui; Miaoxin Li; Pak C Sham; Stacey S Cherny
Journal:  BMC Res Notes       Date:  2011-10-07

10.  Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.

Authors:  Idan Menashe; Jonine D Figueroa; Montserrat Garcia-Closas; Nilanjan Chatterjee; Nuria Malats; Antoni Picornell; Dennis Maeder; Qi Yang; Ludmila Prokunina-Olsson; Zhaoming Wang; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Amy Hutchinson; Yi-Ping Fu; Wei Tang; Laurie Burdette; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Alan Schned; Gerald Andriole; Amanda Black; Eric J Jacobs; Ryan W Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; Neil E Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nathaniel Rothman
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

View more
  22 in total

1.  Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.

Authors:  Denise A Hien; Aimee N C Campbell; Lesia M Ruglass; Lissette Saavedra; Abigail G Mathews; Grace Kiriakos; Antonio Morgan-Lopez
Journal:  J Subst Abuse Treat       Date:  2015-04-07

2.  Unmet challenges in immune-mediated hepatobiliary diseases.

Authors:  Ulrich Beuers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis.

Authors:  Marco Carbone; Ana Lleo; Richard N Sandford; Pietro Invernizzi
Journal:  Eur J Immunol       Date:  2014-02-27       Impact factor: 5.532

4.  Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance.

Authors:  Heekyong R Bae; Patrick S C Leung; Koichi Tsuneyama; Julio C Valencia; Deborah L Hodge; Seohyun Kim; Tim Back; Megan Karwan; Anand S Merchant; Nobuyuki Baba; Dechun Feng; Ogyi Park; Bin Gao; Guo-Xiang Yang; M Eric Gershwin; Howard A Young
Journal:  Hepatology       Date:  2016-06-15       Impact factor: 17.425

5.  Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.

Authors:  Yin-Hu Wang; Wei Yang; Jing-Bo Yang; Yan-Jie Jia; Wei Tang; M Eric Gershwin; William M Ridgway; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2015-02-17       Impact factor: 7.094

Review 6.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

7.  A network-based kernel machine test for the identification of risk pathways in genome-wide association studies.

Authors:  Saskia Freytag; Juliane Manitz; Martin Schlather; Thomas Kneib; Christopher I Amos; Angela Risch; Jenny Chang-Claude; Joachim Heinrich; Heike Bickeböller
Journal:  Hum Hered       Date:  2014-01-14       Impact factor: 0.444

8.  RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.

Authors:  Yan-Li Hao; Zhao-Lian Bian; Lin-Ling Ju; Yuan Liu; Gang Qin
Journal:  Dig Dis Sci       Date:  2019-08-03       Impact factor: 3.199

Review 9.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 10.  Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis.

Authors:  Ignazio Grattagliano; Giuseppe Calamita; Tiziana Cocco; David Q-H Wang; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.